Bridgeway Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-500
| Closed | -$253K | – | 1417 |
|
|
2023
Q3 | $253K | Sell |
500
-15
| -3% | -$7.59K | 0.01% | 1048 |
|
|
2023
Q2 | $269K | Buy |
515
+15
| +3% | +$7.83K | 0.01% | 1070 |
|
|
2023
Q1 | $288K | Hold |
500
| – | – | 0.01% | 1018 |
|
|
2022
Q4 | $275K | Hold |
500
| – | – | 0.01% | 1011 |
|
|
2022
Q3 | $254K | Sell |
500
-4,500
| -90% | -$2.29M | 0.01% | 1088 |
|
|
2022
Q2 | $2.72M | Sell |
5,000
-4,120
| -45% | -$2.24M | 0.06% | 452 |
|
|
2022
Q1 | $5.39M | Sell |
9,120
-21,975
| -71% | -$13M | 0.1% | 327 |
|
|
2021
Q4 | $20.7M | Buy |
31,095
+26,475
| +573% | +$17.7M | 0.39% | 29 |
|
|
2021
Q3 | $2.64M | Buy |
4,620
+4,120
| +824% | +$2.35M | 0.05% | 510 |
|
|
2021
Q2 | $252K | Sell |
500
-5,100
| -91% | -$2.57M | ﹤0.01% | 1234 |
|
|
2021
Q1 | $2.56M | Buy |
5,600
+400
| +8% | +$183K | 0.05% | 502 |
|
|
2020
Q4 | $2.42M | Buy |
5,200
+4,700
| +940% | +$2.19M | 0.05% | 460 |
|
|
2020
Q3 | $221K | Buy |
+500
| New | +$221K | 0.01% | 1161 |
|
|
2019
Q1 | – | Sell |
-21,160
| Closed | -$4.74M | – | 1400 |
|
|
2018
Q4 | $4.74M | Buy |
+21,160
| New | +$4.74M | 0.06% | 215 |
|
|
2016
Q4 | – | Sell |
-1,400
| Closed | -$223K | – | 1464 |
|
|
2016
Q3 | $223K | Hold |
1,400
| – | – | ﹤0.01% | 1306 |
|
|
2016
Q2 | $207K | Buy |
+1,400
| New | +$207K | ﹤0.01% | 1300 |
|
|
2013
Q4 | – | Sell |
-27,300
| Closed | -$2.52M | – | 1438 |
|
|
2013
Q3 | $2.52M | Buy |
27,300
+20,400
| +296% | +$1.88M | 0.09% | 321 |
|
|
2013
Q2 | $584K | Buy |
+6,900
| New | +$584K | 0.02% | 875 |
|